Medpace (MEDP) Competitors $434.35 +5.56 (+1.30%) Closing price 04:00 PM EasternExtended Trading$433.98 -0.37 (-0.08%) As of 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEDP vs. ICLR, EHC, ELV, HIMS, IQV, WCN, TCOM, RDDT, TOST, and CPAYShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include Icon (ICLR), Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), Waste Connections (WCN), Trip.com Group (TCOM), Reddit (RDDT), Toast (TOST), and Corpay (CPAY). Medpace vs. Its Competitors Icon Encompass Health Elevance Health Hims & Hers Health IQVIA Waste Connections Trip.com Group Reddit Toast Corpay Icon (NASDAQ:ICLR) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings. Does the media prefer ICLR or MEDP? In the previous week, Medpace had 12 more articles in the media than Icon. MarketBeat recorded 14 mentions for Medpace and 2 mentions for Icon. Icon's average media sentiment score of 1.81 beat Medpace's score of 1.73 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Medpace 14 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is ICLR or MEDP more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.82% 10.95% 6.23% Medpace 18.74%67.66%21.86% Which has more volatility & risk, ICLR or MEDP? Icon has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Do analysts recommend ICLR or MEDP? Icon presently has a consensus target price of $219.54, suggesting a potential upside of 38.56%. Medpace has a consensus target price of $406.60, suggesting a potential downside of 6.39%. Given Icon's stronger consensus rating and higher possible upside, research analysts plainly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.81Medpace 3 Sell rating(s) 9 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93 Do insiders & institutionals hold more shares of ICLR or MEDP? 95.6% of Icon shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 44.0% of Icon shares are owned by company insiders. Comparatively, 20.3% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger valuation and earnings, ICLR or MEDP? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.55$791.47M$9.7216.30Medpace$2.11B5.79$404.39M$13.4532.29 SummaryIcon beats Medpace on 9 of the 17 factors compared between the two stocks. Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.20B$7.33B$5.45B$9.68BDividend YieldN/A2.83%3.99%4.14%P/E Ratio32.2965.5930.1125.01Price / Sales5.7926.06379.5578.79Price / Cash30.8526.5935.9458.58Price / Book70.7417.898.135.68Net Income$404.39M$243.10M$3.26B$265.68M7 Day Performance2.66%2.42%1.15%2.51%1 Month Performance34.68%-2.92%2.81%1.88%1 Year Performance13.56%21.32%28.41%24.00% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.3492 of 5 stars$434.35+1.3%$406.60-6.4%+16.5%$12.20B$2.11B32.295,900Positive NewsICLRIcon4.551 of 5 stars$189.66+1.4%$219.54+15.8%-48.5%$15.32B$8.28B19.5141,900Positive NewsEHCEncompass Health4.8972 of 5 stars$107.10-0.5%$131.50+22.8%+37.1%$10.80B$5.37B22.1340,000Earnings ReportAnalyst ForecastAnalyst RevisionELVElevance Health4.9379 of 5 stars$286.00-1.1%$418.19+46.2%-45.6%$64.40B$189.25B12.17104,200Positive NewsHIMSHims & Hers Health2.6964 of 5 stars$58.67+1.8%$39.83-32.1%+218.3%$13.13B$1.48B85.031,637Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionIQVIQVIA4.9032 of 5 stars$197.73-0.7%$228.62+15.6%-22.0%$33.61B$15.41B28.6288,000Positive NewsWCNWaste Connections4.6487 of 5 stars$186.07-0.5%$215.00+15.5%+4.8%$48.08B$8.92B75.0323,854Positive NewsTCOMTrip.com Group4.8507 of 5 stars$63.50-1.4%$77.25+21.7%+51.7%$41.48B$7.30B18.4141,073News CoveragePositive NewsRDDTReddit3.1 of 5 stars$151.81+1.4%$143.08-5.7%+317.9%$28.01B$1.45B257.312,233Trending NewsInsider TradeTOSTToast2.476 of 5 stars$49.00+0.6%$43.17-11.9%+100.6%$24.40B$4.96B213.045,700Trending NewsEarnings ReportAnalyst ForecastCPAYCorpay4.0123 of 5 stars$333.69-0.6%$401.07+20.2%+12.8%$23.68B$4.05B23.4011,200Earnings ReportAnalyst Forecast Related Companies and Tools Related Companies Icon Alternatives Encompass Health Alternatives Elevance Health Alternatives Hims & Hers Health Alternatives IQVIA Alternatives Waste Connections Alternatives Trip.com Group Alternatives Reddit Alternatives Toast Alternatives Corpay Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEDP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDP Stock Alerts